Sihuan Pharmaceutical Holdings Group Ltd.

SZSC:460 Stock Report

Market Cap: HK$6.1b

Sihuan Pharmaceutical Holdings Group Management

Management criteria checks 4/4

Sihuan Pharmaceutical Holdings Group's CEO is Weicheng Guo, appointed in Oct 2014, has a tenure of 10.17 years. total yearly compensation is CN¥3.00M, comprised of 100% salary and 0% bonuses, including company stock and options. directly owns 0.12% of the company’s shares, worth HK$7.49M. The average tenure of the management team and the board of directors is 2.2 years and 8.8 years respectively.

Key information

Weicheng Guo

Chief executive officer

CN¥3.0m

Total compensation

CEO salary percentage100.0%
CEO tenure10.2yrs
CEO ownership0.1%
Management average tenure2.2yrs
Board average tenure8.8yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Weicheng Guo's remuneration changed compared to Sihuan Pharmaceutical Holdings Group's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024n/an/a

-CN¥38m

Mar 31 2024n/an/a

-CN¥46m

Dec 31 2023CN¥3mCN¥3m

-CN¥54m

Jun 30 2023n/an/a

-CN¥2b

Mar 31 2023n/an/a

-CN¥2b

Dec 31 2022CN¥3mCN¥3m

-CN¥2b

Jun 30 2022n/an/a

-CN¥144m

Mar 31 2022n/an/a

CN¥141m

Dec 31 2021CN¥6mCN¥6m

CN¥427m

Sep 30 2021n/an/a

CN¥681m

Jun 30 2021n/an/a

CN¥945m

Mar 31 2021n/an/a

CN¥727m

Dec 31 2020CN¥6mCN¥6m

CN¥508m

Sep 30 2020n/an/a

-CN¥14m

Jun 30 2020n/an/a

-CN¥537m

Mar 31 2020n/an/a

-CN¥2b

Dec 31 2019CN¥6mCN¥6m

-CN¥3b

Sep 30 2019n/an/a

-CN¥2b

Jun 30 2019n/an/a

-CN¥1b

Mar 31 2019n/an/a

CN¥238m

Dec 31 2018CN¥6mCN¥6m

CN¥2b

Sep 30 2018n/an/a

CN¥1b

Jun 30 2018n/an/a

CN¥1b

Mar 31 2018n/an/a

CN¥1b

Dec 31 2017CN¥6mCN¥6m

CN¥1b

Compensation vs Market: Weicheng's total compensation ($USD411.03K) is about average for companies of similar size in the Hong Kong market ($USD479.63K).

Compensation vs Earnings: Weicheng's compensation has been consistent with company performance over the past year.

CEO

Weicheng Guo (60 yo)

10.2yrs

Tenure

CN¥3,000,000

Compensation

Dr. Weicheng Guo co-founded Sihuan Pharmaceutical Holdings Group Ltd. and has been its Chief Executive Officer since October 20, 2014. Dr. Guo is responsible for the overall operations of Sihuan Pharmaceut...

Leadership Team

NamePositionTenureCompensationOwnership
Fengsheng Che
Co-Founder & Executive Chairman18.6yrsCN¥7.00m5.34%
HK$ 328.3m
Weicheng Guo
Deputy Chairman & CEO10.2yrsCN¥3.00m0.12%
HK$ 7.5m
Guili Miao
Deputy CEO2.2yrsCN¥5.05mno data
Jionglong Zhang
Executive Director4.1yrsCN¥646.00k2.14%
HK$ 131.3m
Yanling Chen
Joint Company Secretary & Executive Director2.2yrsCN¥1.77mno data
Kin Wai Li
Joint Company Secretary2.2yrsno datano data
Xianhui Meng
Deputy General Managerno dataCN¥4.26mno data

2.2yrs

Average Tenure

60yo

Average Age

Experienced Management: 460's management team is considered experienced (2.2 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Fengsheng Che
Co-Founder & Executive Chairman18.6yrsCN¥7.00m5.34%
HK$ 328.3m
Weicheng Guo
Deputy Chairman & CEO18.6yrsCN¥3.00m0.12%
HK$ 7.5m
Guili Miao
Deputy CEO2.2yrsCN¥5.05mno data
Jionglong Zhang
Executive Director6.7yrsCN¥646.00k2.14%
HK$ 131.3m
Yanling Chen
Joint Company Secretary & Executive Director6.7yrsCN¥1.77mno data
Wah Kwong Tsang
Independent Non-Executive Director11.3yrsCN¥371.00kno data
Xun Zhu
Independent Non-Executive Director10.8yrsCN¥371.00kno data
Guan Wang
Independent Non-Executive Director1.7yrsCN¥202.00kno data

8.8yrs

Average Tenure

61yo

Average Age

Experienced Board: 460's board of directors are considered experienced (8.8 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/20 18:00
End of Day Share Price 2024/12/20 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Sihuan Pharmaceutical Holdings Group Ltd. is covered by 24 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Shaojing TongBofA Global Research
Harry HeChina Galaxy International Securities (Hong Kong)
Sze Chuen TamCore Pacific -Yamaichi International (H.K.) Limited